Cary Pfeffer - Net Worth and Insider Trading

Cary Pfeffer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cary Pfeffer owns 4 companies in total, including Jounce Therapeutics Inc (JNCE) , Neon Therapeutics Inc (NTGN) , and Sesen Bio Inc (SESN) among others .

Click here to see the complete history of Cary Pfeffer’s form 4 insider trades.

Insider Ownership Summary of Cary Pfeffer

Ticker	Comapny	Transaction Date	Type of Owner
JNCE	Jounce Therapeutics Inc	2017-01-26	director
NTGN	Neon Therapeutics Inc	2020-05-06	director
SESN	Sesen Bio Inc	2014-02-05	director
		2014-02-05	director

Cary Pfeffer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cary Pfeffer Ownership Network

Ownership Network List of Cary Pfeffer

No Data

Ownership Network Relation of Cary Pfeffer

Cary Pfeffer Owned Company Details

What does Jounce Therapeutics Inc do?

Who are the key executives at Jounce Therapeutics Inc?

Cary Pfeffer is the director of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .

Jounce Therapeutics Inc (JNCE) Insider Trades Summary

Over the past 18 months, Cary Pfeffer made no insider transaction in Jounce Therapeutics Inc (JNCE). Other recent insider transactions involving Jounce Therapeutics Inc (JNCE) include a net sale of 39,228 shares made by Richard /ca/ Murray ,

In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,228 shares of Jounce Therapeutics Inc (JNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,228 shares.

Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jounce Therapeutics Inc Insider Transactions

No Available Data

What does Neon Therapeutics Inc do?

Who are the key executives at Neon Therapeutics Inc?

Cary Pfeffer is the director of Neon Therapeutics Inc. Other key executives at Neon Therapeutics Inc include President of R&D Richard Gaynor , director & 10 percent owner Robert I Tepper , and Chief Financial Officer Yasir B. Al-wakeel .

Neon Therapeutics Inc (NTGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neon Therapeutics Inc (NTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neon Therapeutics Inc (NTGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neon Therapeutics Inc (NTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neon Therapeutics Inc Insider Transactions

No Available Data

What does Sesen Bio Inc do?

Who are the key executives at Sesen Bio Inc?

Cary Pfeffer is the director of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .

Sesen Bio Inc (SESN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sesen Bio Inc Insider Transactions

No Available Data

What does CARISMA Therapeutics Inc do?

Who are the key executives at CARISMA Therapeutics Inc?

Cary Pfeffer is the director of CARISMA Therapeutics Inc. Other key executives at CARISMA Therapeutics Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .

CARISMA Therapeutics Inc (CARM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.

CARISMA Therapeutics Inc Insider Transactions

No Available Data

Cary Pfeffer Mailing Address

Above is the net worth, insider trading, and ownership report for Cary Pfeffer. You might contact Cary Pfeffer via mailing address: C/o Eleven Biotherapeutics, 215 First Street, Suite 400, Cambridge Ma 02142.

Discussions on Cary Pfeffer

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.